Data as of:
brimindinvest.com / compare / infy-vs-ctshLIVE
INFY
INFY ·
$11.70
-6.25% this month
VERSUS
COMPARE
CTSH
CTSH ·
$62.31
+11.71% this month
Comparison scoreboard
CTSH LEADS 4/5
AI Scorei
INFY 37.7
CTSH 38.5
1Y Returni
INFY -26.87%
CTSH -13.24%
Fwd P/Ei
INFY 13.78
CTSH 9.86
Target Up.i
INFY +1.30%
CTSH +3.01%
Op. Margini
INFY 21.17%
CTSH 17.48%
Metrics last refreshed: 9/8/2026
Quick take

INFY vs CTSH Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

Compare Infosys' India-based delivery model against Cognizant's US-headquartered, healthcare-heavy client base.

Use this Infosys vs Cognizant comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.

Live analysis · updated 9/8/2026

CTSH holds the edge across 4 of 5 key metrics in this comparison. CTSH leads on both 1-year return (-13.24%) and forward P/E quality (9.86x vs 13.78x for INFY), a relatively favorable combination of momentum and valuation. On fundamentals, CTSH is growing revenue faster (4.50%), while INFY maintains the higher operating margin (21.17%) — a classic growth-versus-profitability split. Analyst consensus implies similar upside for both: +1.30% for INFY and +3.01% for CTSH.

Want a full valuation workup? 16-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
INFY
CTSH
Recent returns
INFY
CTSH
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

INFY · 12 analysts
STRONG BUYHOLDSTRONG SELL
Hold (2.7/5.0)
Price target range
analyst low$9.00
analyst high$14.10
analyst mean$11.85
current price$11.70
+1.3% upside to analyst mean
CTSH
Price target range
analyst mean$64.18
current price$62.31
+3.0% upside to analyst mean
Performance & AI score
Performance & AI score
MetricINFYCTSH
AI scorei37.738.5
AI ranki#1418#1319
Latest closei$11.70$62.31
1M returni-6.25%+11.71%
6M returni-16.99%-5.28%
1Y returni-26.87%-13.24%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodINFYCTSH
1Y ago$7.59K (-24.1%)
started 2025-09-04
$8.72K (-12.8%)
started 2025-09-04
5Y ago$6.65K (-33.5%)
started 2021-09-07
$9.21K (-7.9%)
started 2021-09-07
10Y ago$25.96K (+159.6%)
started 2016-09-06
$13.37K (+33.7%)
started 2016-09-06

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricINFYCTSH
Market capi$47.39B$28.07B
Trailing P/Ei14.4413.37
Forward P/Ei13.789.86
Price/Salesi2.33N/A
EV/Revenuei4.561.34
Analyst targeti$11.85$64.18
Target upsidei+1.30%+3.01%
Growth, profitability & risk
Growth, profitability & risk
MetricINFYCTSH
Revenue growthi2.90%4.50%
Earnings growthi5.30%3.80%
EPS growthi+5.30%+3.80%
FCF margini+15.59%+10.24%
Operating margini21.17%17.48%
Profit margini16.37%10.26%
ROIC proxyi32.00%14.92%
Return on equityi32.00%14.92%
Dividend yieldi4.48%2.12%
Betai0.110.83
Debt/equityi9.5414.48
Current ratioi1.862.18
Quick ratioi1.591.68
Correlation

Over the past year, INFY and CTSH have moved moderately in the same direction (correlation of 0.70), based on daily returns.

1Y
0.70
-1.0+1.0
5Y
0.60
-1.0+1.0
10Y
0.58
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
INFY max drawdowni47.00%
CTSH max drawdowni55.33%
INFY max wkly dropi15.42%
CTSH max wkly dropi19.82%
5Y risk snapshot
INFY max drawdowni54.40%
CTSH max drawdowni56.99%
INFY max wkly dropi15.42%
CTSH max wkly dropi19.82%
10Y risk snapshot
INFY max drawdowni54.40%
CTSH max drawdowni56.99%
INFY max wkly dropi20.53%
CTSH max wkly dropi19.82%
Performance metrics by period
Performance metrics by period
PeriodMetricINFYCTSH
1YGrowthi-26.87%-12.79%
CAGRi-26.88%-12.81%
Volatilityi39.33%40.00%
Sharpe ratioi-0.71-0.25
Sortino ratioi-0.98-0.35
Max drawdowni47.00%55.33%
Current drawdowni40.89%28.13%
Avg drawdowni23.46%21.88%
Ulcer Indexi28.62%28.17%
Max daily dropi9.84%10.49%
Max wkly dropi15.42%19.82%
5YGrowthi-42.63%-13.28%
CAGRi-10.53%-2.81%
Volatilityi29.43%29.48%
Sharpe ratioi-0.38-0.10
Sortino ratioi-0.53-0.14
Max drawdowni54.40%56.99%
Current drawdowni49.14%30.80%
Avg drawdowni25.17%21.14%
Ulcer Indexi28.11%24.33%
Max daily dropi9.84%13.77%
Max wkly dropi15.42%19.82%
10YGrowthi+88.36%+18.76%
CAGRi+6.54%+1.74%
Volatilityi28.89%29.68%
Sharpe ratioi0.210.06
Sortino ratioi0.290.08
Max drawdowni54.40%56.99%
Current drawdowni49.14%30.80%
Avg drawdowni16.13%17.04%
Ulcer Indexi21.07%20.90%
Max daily dropi12.11%17.18%
Max wkly dropi20.53%19.82%
AI Prediction Signali
Members only
Next 5 trading days
INFY
+2.8%BUY
CTSH
+1.1%HOLD
Next 30 trading days
INFY
+6.4%BUY
CTSH
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryINFYCTSH
CompanyINFYCTSH
SectorN/ATechnology
IndustryInformation Technology ServicesInformation Technology Services
Core businessInfosys Limited provides consulting, technology, outsourcing, and digital services worldwide.Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp